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Pospital Improvement in Time
o Reperfusion in Patients With
cute Myocardial Infarction, 1999 to 2002
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ew Haven, Connecticut; Charlottesville, Virginia; Denver, Colorado; and San Francisco, California
OBJECTIVES The purpose of this study was to analyze recent trends in door-to-reperfusion time and to
identify hospital characteristics associated with improved performance.
BACKGROUND Rapid reperfusion improves survival for patients with acute ST-segment elevation myocardial
infarction (STEMI).
METHODS In this retrospective observational study from the National Registry of Myocardial Infarction
(NRMI)-3 and -4, between 1999 and 2002, we analyzed door-to-needle and door-to-balloon
times in patients admitted with STEMI and receiving fibrinolytic therapy (n  68,439
patients in 1,015 hospitals) or percutaneous coronary intervention (n 33,647 patients in 421
hospitals) within 6 h of hospital arrival.
RESULTS In 1999, only 46% of the patients in the fibrinolytic therapy cohort were treated within the
recommended 30-min door-to-needle time; only 35% of the patients in the percutaneous
coronary intervention cohort were treated within the recommended 90-min door-to-balloon
time. Improvement in these times to reperfusion over the four-year study period was not
statistically significant (door-to-needle:0.01 min/year, 95% confidence interval [CI]0.24
to 0.23, p  0.9; door-to-balloon: 0.57 min/year, 95% CI 1.24 to 0.10, p  0.09).
Only 33% (337 of 1,015) of hospitals improved door-to-needle time by more than one
min/year, and 26% (110 of 421) improved door-to-balloon time by more than three min/year.
No hospital characteristic was significantly associated with improvement in door-to-needle
time. Only high annual percutaneous coronary intervention volume and location in New
England were significantly associated with greater improvement in door-to-balloon time.
CONCLUSIONS Fewer than one-half of patients with STEMI receive reperfusion in the recommended
door-to-needle or door-to-balloon time, and mean time to reperfusion has not decreased
significantly in recent years. Relatively few hospitals have shown substantial
improvement. (J Am Coll Cardiol 2006;47:45–51) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.071Cardiology Foundation
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Shorter time to reperfusion is associated with better survival
or patients with ST-segment elevation myocardial infarc-
ion (STEMI), whether they receive fibrinolytic therapy
1,2) or percutaneous coronary intervention (PCI) (3–5).
ecently published guidelines recommend goals of 30 min
or presentation at the hospital to the administration of
brinolytic therapy (door-to-needle time) and 90 min for
resentation at the hospital to the inflation of an angioplasty
alloon (door-to-balloon time) (6). The Centers for Medi-
are and Medicaid Services and the Joint Commission on
From the *Department of Medicine, Section of Cardiovascular Medicine, †Section
f Health Policy and Administration, Department of Epidemiology and Public
ealth, and the ‡Robert Wood Johnson Clinical Scholars Program, Yale University
chool of Medicine, New Haven, Connecticut; §Flying Buttress Associates, Char-
ottesville, Virginia; Clinical Research Unit, Kaiser Permanente, Denver, Colorado;
Departments of Emergency Medicine and Preventive Medicine and Biometrics,
niversity of Colorado Health Sciences Center, Denver, Colorado; #Genentech Inc.,
outh San Francisco, California; and the **Center for Outcomes Research and
valuation, Yale-New Haven Health System, New Haven, Connecticut. Martha
laney is employed by Genentech Inc. This research was supported by the National
eart, Lung, and Blood Institute, R01HS10407-01. The NHLBI did not play a role
n the design and conduct of the study; collection, management, analysis, and
nterpretation of the data; or preparation, review, or approval of the manuscript.R
Manuscript received January 13, 2005; revised manuscript received March 29,
005, accepted April 11, 2005.ccreditation of Healthcare Organizations have identified
ime to reperfusion as an important quality indicator for
cute myocardial infarction (AMI).
No contemporary information exists about hospital per-
ormance in achieving national benchmarks for time to
eperfusion. Previous investigators determined that the av-
rage door-to-needle time decreased from 62 min in 1990 to
8 min in 1999 (7); however, this average time in 1999 was
till longer than the guideline recommendations, and no
nformation was provided on door-to-balloon time. More-
ver, studies of time to reperfusion did not evaluate
ospital-level performance.
Several related questions remain. First, at the hospital
evel, has time to fibrinolytic therapy decreased in more
ecent years and are hospitals reaching the guideline recom-
endations? Second, has the time to PCI improved? Third,
hat is the variation in individual hospital improvement in
ime to reperfusion? Finally, are there hospital characteris-
ics associated with improvement? To address these ques-
ions, we used detailed patient-level and hospital-level
ongitudinal data from a national sample of patients with
TEMI admitted from 1999 to 2002 from the National
egistry of Myocardial Infarction (NRMI)-3 and -4 (8).
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tudy design and sample. We used NRMI, a voluntary
MI registry sponsored by Genentech Inc. (South San
rancisco, California), to obtain a cohort of patients with
TEMI who received acute reperfusion therapy with either
brinolytic therapy or primary PCI. The NRMI criteria
9,10) include a diagnosis of AMI according to the Inter-
ational Classification of Diseases-Ninth Revision-Clinical
odification (code 410.X1) and any one of the following
riteria: total creatine kinase or creatine kinase MB that was
wo or more times the upper limit of the normal range or
levations in alternative cardiac markers; electrocardio-
raphic evidence of AMI; or nuclear medicine testing,
chocardiography, or autopsy evidence of AMI. During our
tudy period of January 1, 1999, to December 31, 2002,
here were 830,473 AMI admissions in NRMI. We ex-
luded patients who had neither ST-segment elevation (in 2
r more leads) nor left bundle branch block on the first
lectrocardiogram (ECG) (n  535,993); who were trans-
erred from another acute care institution (n  72,756);
hose AMI symptom onset was after the admit date and
ime (n  5,088); who were without chest pain and in
hom symptom onset time was not known (n  20,415);
hose first ECG obtained was not the diagnostic ECG (the
CG with ST-segment elevation or left bundle branch block;
 17,066); and those with time of diagnostic ECG missing,
ore than 1 h before presentation, or more than 6 h after
resentation (n  6,335).
From the 172,820 remaining patients, we analyzed fi-
rinolytic therapy and PCI separately. We assigned patients
ho received both therapies to the group on the basis of the
herapy they received first. From the patients who received
brinolytic therapy (n  73,422), we excluded those with
oor-to-needle time that was negative, more than 6 h, or
issing (n  512); those who received fibrinolytic therapy
fter PCI (n  13); those in hospitals with fewer than 20
otal patients (n 4,436); and those from the single NRMI
ospital outside of the 50 states (n  22), leaving a final
brinolytic therapy cohort of 68,439 patients from 1,015
ospitals. From the patients who received PCI (n 
6,763), we excluded those with door-to-balloon time that
as negative, more than 6 h, or missing (n  891); those
ho received PCI after fibrinolytic therapy (n  507); and
Abbreviations and Acronyms
AMI  acute myocardial infarction
CI  confidence interval
ECG  electrocardiogram
NRMI  National Registry of Myocardial Infarction
PCI  percutaneous coronary intervention
STEMI  ST-segment elevation myocardial infarctionhose in hospitals with fewer than 20 total patients (n  r,718), leaving a final PCI cohort of 33,647 patients from
21 hospitals.
Because NRMI is a voluntary registry, many hospitals did
ot participate consistently over the entire time period.
ome hospitals started submitting data later than 1999,
ome stopped submitting data during the study period, and
ome intermittently submitted data. We repeated analyses
ith hospitals that reported at least five cases for each year of
he study period (as opposed to the original cohort with
ospitals that reported an average of at least five cases/year).
he results from these smaller cohorts (for both fibrinolytic
herapy and PCI) were not substantially different from those
f the more inclusive cohorts. Thus, we present only the
nalyses using the larger cohort.
ata collection and measures. Our principal outcome was
he time in minutes between hospital arrival and the delivery
f reperfusion therapy, as noted in the medical record and
ecorded in the NRMI case report form. Calendar time was
easured in elapsed time from the beginning of the study
eriod.
Hospital characteristics included U.S. Census division;
wnership (government, nonprofit, for-profit); cardiac fa-
ilities (open heart surgery, cardiac catheterization labora-
ory only, other); annual reperfusion volume (20, 20 to 40,
40 for fibrinolytic therapy and 15, 15 to 50, 50 for
CI); and reperfusion specialization (percentage of all
eperfused STEMI patients in the hospital who received the
iven strategy). We classified hospitals on the basis of urban
residence in a county with a population of at least 50,000)
ersus rural location and teaching status (i.e., participation
n a residency or fellowship training program accredited by
he Liaison Committee on Medical Education). Data for
ospital characteristics were obtained from the American
ospital Association Annual Survey of Hospitals (11) and
he SMG data set (SMG Marketing Group Inc., Chicago,
llinois).
Patient demographic and clinical covariates included
ociodemographic variables (gender, age, race/ethnicity, and
ayer type); medical history (smoker, chronic renal insuffi-
iency, previous AMI, hypertension, family history of cor-
nary artery disease, hypercholesterolemia, congestive heart
ailure, previous percutaneous transluminal coronary angio-
lasty, previous coronary artery bypass graft surgery, chronic
bstructive pulmonary disease, stroke, angina, diabetes);
resentation characteristics (whether a pre-hospital ECG
as performed, chest pain at presentation, systolic blood
ressure, pulse, heart failure); the results of the diagnostic
CG (number of leads with ST-segment elevation, AMI
ocation, ST-segment depression, nonspecific ST-T-wave
hanges, Q-wave); the admission time of day (day, evening,
r night); and admission day of week (weekday or weekend).
tatistical analysis. We reported the number of patients
ho were administered fibrinolytic therapy or PCI within
he recommended time frame for each year of the study. We
hen examined differences in hospital performance (geomet-
ic mean time to reperfusion) and improvement (change
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January 3, 2006:45–51 Improvement in Time to Reperfusion in STEMIver calendar time in geometric mean time to reperfusion)
ith multivariable hierarchical models (12). Hierarchical
odels were used to account for the non-independence of
bservations in this sample, in which patients were clustered
ithin participating NRMI hospitals. In addition, hierar-
hical models allowed us to estimate variation in perfor-
ance and improvement across hospitals by modeling both
he intercept and calendar time as random effects. We
dentified hospital characteristics that were associated with
reater improvement using cross-level interactions between
alendar time and hospital characteristics.
To account for potential floor and ceiling effects (hospi-
als starting with very high or low treatment times having
ore or less opportunity to improve over time) and for
egression to the mean (13), each model also included terms
epresenting the interaction of calendar time with hospital
aseline performance. Baseline performance was calculated
s the median time to reperfusion of the first 10 cases
eported in the study period for a given hospital. Time to
eperfusion was treated as a continuous variable, and log
ransformation was used to correct for skewness (14). For
asier interpretation, we transformed coefficients back into
atural units with geometric means or simulation methods
15). Statistical analyses were performed with SAS versions
.12 and 8.2 (SAS Inc., Cary, North Carolina), Stata version
.0 (Stata Corp., College Station, Texas), and HLM version 5
SSI, Lincolnwood, Illinois). The authors had full access to all
he data in the study and take responsibility for the integrity of
he data and the accuracy of the data analysis.
ESULTS
ample characteristics. The characteristics of the patients
ncluded in the fibrinolytic therapy cohort (n 68,439) and
he PCI cohort (n  33,647) are displayed in Table 1. The
ohorts were predominantly male and white, with a signifi-
ant proportion of patients having a prior diagnosis of coronary
rtery disease and/or traditional cardiac risk factors. Over 93%
ad chest pain, 11% were in overt heart failure, and about 2%
ad left bundle branch block. The characteristics of the
ospitals in the study are shown in Table 2. A greater
roportion of hospitals in the fibrinolytic therapy cohort were
ural teaching hospitals, whereas the PCI cohort included a
reater proportion of urban teaching hospitals.
uideline adherence. In 1999, 46% (11,107 of 24,024) of
atients in the fibrinolytic therapy cohort were treated
ithin 30 min, and 35% (3,104 of 8,798) of the patients in
he PCI cohort were treated within 90 min, the recom-
ended times (16,17) (Figs. 1A and 1B). These proportions
ncreased by 1% and 2%, respectively, over the next three
ears. In addition, the proportion of patients receiving
brinolytic therapy after 40 min or PCI after 120 min did
ot change substantially.
ospital characteristics associated with performance. With
ultivariable hierarchical modeling, the mean door-to-eedle time over the study period, adjusted for both patient snd hospital characteristics, was 34.3 min (95% confidence
nterval [CI] 33.9 to 34.7). Several hospital characteristics
ere significantly associated with performance (Table 2).
oor-to-needle times differed by geographic location, with
est times in the West North Central (Minnesota, Iowa,
issouri, North Dakota, South Dakota, Nebraska, and
ansas) and Mountain (Montana, Idaho, Wyoming, Ne-
ada, Utah, Colorado, Arizona, and New Mexico) divisions.
rban teaching hospitals had longer times than nonteach-
ng hospitals or rural teaching hospitals. Hospitals with
igher volumes and those with higher proportions of fi-
rinolytic therapy to total reperfusion therapy (reperfusion
able 1. Description of the Patient Samples
Fibrinolytic
Therapy
Cohort
(n  68,439)
PCI Cohort
(n  33,647)
emographics
Age, yrs 61.7 (13.0) 61.8 (13.2)
Women 30.5% (20,867) 29.8% (10,027)
Race
White 85.9% (58,790) 85.4% (28,718)
Black 4.9% (3,376) 5.1% (1,703)
Hispanic 3.5% (2,423) 3.5% (1,178)
Other/unknown 5.6% (3,850) 6.1% (2,048)
edical history
Congestive heart failure 4.0% (2,707) 3.3% (1,103)
Hypertension 47.8% (32,680) 49.1% (16,525)
Diabetes 19.5% (13,340) 19.2% (6,464)
Smoker 39.1% (26,753) 38.2% (12,854)
Stroke 3.4% (2,336) 4.8% (1,610)
Percutaneous transluminal
coronary angioplasty
9.8% (6,696) 14.5% (4,872)
Coronary artery bypass
graft surgery
6.5% (4,418) 5.9% (1,991)
Chronic obstructive
pulmonary disease
8.2% (5,600) 7.9% (2,671)
Hypercholesterolemia 33.6% (22,978) 37.5% (12,603)
Hormone replacement
therapy
2.8% (1,941) 3.1% (1,037)
Chronic renal insufficiency 2.1% (1,416) 2.5% (847)
Coronary artery disease 30.9% (21,140) 28.7% (9,658)
Angina 7.1% (4,861) 8.0% (2,682)
Previous myocardial
infarction
16.3% (11,128) 16.5% (5,535)
resentation
Chest pain 95.0% (65,017) 93.5% (31,473)
Heart failure
None 89.2% (61,043) 88.1% (29,636)
Rales/jugular venous
distension
7.4% (5,095) 6.7% (2,251)
Pulmonary edema 2.2% (1,512) 2.0% (680)
Shock 1.2% (789) 3.2% (1,080)
ST-segment elevation
Left bundle branch block 2.0% (1,338) 2.1% (696)
2 leads 10.6% (7,221) 11.2% (3,777)
3–4 leads 67.2% (45,959) 67.0% (22,554)
4 leads 18.8% (12,893) 18.6% (6,274)
Anterior location 32.6% (22,286) 36.4% (12,237)
alues are mean (standard deviation) or % (n).
PCI  percutaneous coronary intervention.pecialization) had modestly shorter times.
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eriod was 108.0 min (95% CI 106.5 to 109.4). Volume and
eperfusion specialization were associated with shorter
oor-to-balloon times. Hospitals in the West North Cen-
ral and New England (Maine, New Hampshire, Vermont,
assachusetts, Rhode Island, and Connecticut) divisions
veraged the best times for the PCI cohort. Teaching and
ural/urban status were not significantly associated with
oor-to-balloon time. Hospitals without cardiac surgery
acilities had shorter times than those with cardiac surgery
acilities (108.4 min vs. 102.4 min). Hospital ownership
tatus did not affect performance for either the fibrinolytic
herapy or PCI cohort.
mprovement. The mean door-to-needle times for the
brinolytic therapy cohort were stable over the four-year
ime period, with a nonsignificant yearly improvement of
.01 min (p  0.9). The decrease in door-to-balloon time
or the PCI cohort also was not statistically significant
able 2. Description of the Hospital Samples and Time to Reper
Characteristics
Fibrinolytic Therapy Hos
Door-to-Needle Tim
n  1,015,
%
Crude,
min
Adjuste
min
eographic location
New England 6.4 33.9 34.6
Middle Atlantic 12.2 35.2 35.4
South Atlantic 16.8 34.5 35.1
East North Central 18.1 32.7 33.6
East South Central 6.5 32.3 33.1
West North Central 6.9 31.9 32.9
West South Central 7.5 35.1 34.5
Mountain 6.3 31.2 32.5
Pacific 19.2 34.7 34.9
wnership
Public 12.2 33.4 34.3
Not-for-profit 78.5 33.7 34.3
Private 9.3 33.9 34.1
eaching
Urban/teaching 20.5 35.7 37.0
Urban/nonteaching 51.7 33.7 34.3
Rural/teaching 1.9 32.6 34.1
Rural/nonteaching 25.9 31.9 33.3
acilities
Open-heart surgery
program
31.8 35.0 35.0
Cardiac catheterization
lab only
35.1 32.9 34.2
Other 33.1 33.2 33.6
nnual volume
20 LYS or 15 PCI 25.9 34.9 35.9
20–40 LYS or 15–50 PCI 44.9 33.7 34.8
40 LYS or 50 PCI 29.2 33.3 33.4
eperfusion specialization†
%LYS or %PCI 20 0.3 52.9 49.3
%LYS or %PCI 20–90 31.6 35.0 35.7
%LYS or %PCI 90 68.1 33.0 33.6
Hierarchical model adjusted for both patient and hospital characteristics and calenda
f PCI patients/total number reperfused).
LYS  fibrinolytic therapy; PCI  percutaneous coronary intervention.0.57 min/year; p  0.09) (Fig. 2). nThe change in mean time to reperfusion by hospital showed
wide distribution nearly centered on 0 for both cohorts (Figs.
A and 3B), with ranges of 5.7 min to 7.4 min for
oor-to-needle times and 12.9 min to 10.1 min for
oor-to-balloon times. Only 33% (337 of 1,015) of hospitals in
he fibrinolytic therapy cohort improved more than one min/
ear, and 26% (110 of 421) of PCI hospitals improved more
han three min/year. Average door-to-needle and door-to-
alloon times worsened by these amounts in 32% (325 of
,015) and 18% (74 of 421) of hospitals, respectively.
ospital characteristics associated with improve-
ent. No hospital characteristic significantly predicted im-
rovement in door-to-needle time for the fibrinolytic therapy
ohort (Table 3). Improvement in hospitals with a higher
roportion of patients receiving fibrinolytic therapy (reperfu-
ion specialization) nearly reached statistical significance (p 
.09). Although total fibrinolytic therapy volume predicted
verall door-to-needle times, fibrinolytic therapy volume did
n
PCI Hospitals Door-to-Balloon Time
p
n  421,
%
Crude,
min
Adjusted,*
min p
0.060 0.001
2.9 99.5 101.9
5.2 106.8 107.9
12.4 107.3 115.6
20.2 105.8 106.0
5.9 108.6 107.1
11.6 96.1 101.7
10.5 111.1 113.3
9.0 107.5 108.7
22.3 103.1 107.1
0.500 0.500
9.0 106.6 108.2
81.9 104.1 107.9
9.0 109.5 108.0
0.001 0.118
47.0 105.0 108.9
46.1 105.0 107.6
2.1 103.3 100.6
4.8 96.7 101.8
0.362 0.040
91.9 105.2 108.4
8.1 98.7 102.4
— — —
0.004 0.001
15.4 114.2 112.6
72.2 107.2 110.4
12.4 97.2 101.6
0.005 0.018
3.1 120.1 110.0
74.1 107.2 108.7
22.8 98.6 99.3
. †Percent of total reperfused patients who had the reperfusion strategy (i.e., numberfusio
pitals
e
d,*
r timeot predict improvement over the study period.
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January 3, 2006:45–51 Improvement in Time to Reperfusion in STEMIIn the PCI cohort, PCI volume significantly predicted
mprovement, with high-volume hospitals (50 PCIs/year)
howing improvement in mean door-to-balloon time (1.9
igure 1. Guideline adherence. Proportions of patients receiving either
brinolytic therapy (A) or percutaneous coronary intervention (B) within
he ACC/AHA recommended times (17) are indicated in black. The
roportions of additional patients receiving late reperfusion, defined as the
ecommended time plus one-third (40 min for fibrinolytic therapy and 120
in for percutaneous coronary intervention) are indicated in white. The
roportions of patients receiving reperfusion between these times are indicated
n the diagonal pattern.
igure 2. Calendar time trend. The geometric mean door-to-needle times
or 68,439 patients (white squares) and geometric mean door-to-balloon
imes for 33,647 patients (black diamonds) for each quarter from Januaryh
999 to December 2002. There was no significant trend for either
oor-to-needle times (p  0.956) or door-to-balloon times (p  0.094).in/year), medium-volume hospitals (15 to 50 PCIs/year)
howing nearly no change in mean time (0.1 min/year),
nd low-volume hospitals (15 PCIs/year) showing an
ncrease in time (1.0 min/year, p  0.033). Thus, in
ddition to being associated with overall performance, PCI
olume predicted improvement over the study period. Hos-
itals in New England showed the most improvement
7.5 min/year). Proportion of PCIs to total reperfusion
herapy (reperfusion specialization) did not predict im-
rovement in door-to-balloon time.
ISCUSSION
espite strong evidence that decreased time to reperfusion for
atients with STEMI is related to improved morbidity and
ortality, we found that less than one-half of these patients
eceived reperfusion therapy within the recommended time in
ny year from 1999 to 2002. Furthermore, we found little
vidence of substantial improvement in time to reperfusion
ver these years. Although the entire cohorts did not improve,
he analysis of the individual hospitals demonstrated a notable
igure 3. Distribution of Improvement. Improvement over the study
eriod for each of the 1,015 hospitals reporting for fibrinolytic therapy (A)
nd for each of the 421 hospitals reporting for percutaneous coronary
ntervention (B). For illustration purposes, those hospitals that improved
y an average of 1 min for fibrinolytic therapy and 3 min for percutaneous
oronary intervention are indicated in white; those hospitals that worsened
y an average of 1 min for fibrinolytic therapy and 3 min for PCI are
ndicated in black; and those hospitals in between these times are indicated
n the diagonal pattern.ospital-level variation in change from 1999 to 2002. Some
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Improvement in Time to Reperfusion in STEMI January 3, 2006:45–51ospitals showed substantial improvement, whereas perfor-
ance worsened in others. Traditional hospital characteristics
enerally were not good predictors of improvement, indicating
need to identify other, perhaps more subtle, reasons why
ome hospitals improve.
Our results extend the work on earlier trends in time to
brinolytic therapy. In an earlier study of the NRMI
atabase, the median door-to-needle time was shown to
ecrease from 62 min to 47 min from 1990 to 1994, with a
ubsequent decrease to 38 min by 1999 (7). This slowing of
mprovement over time is consistent with the lack of change
n door-to-needle times we found from 1999 to 2002. In a
eview of care given to Medicare beneficiaries, a state-by-
tate comparison found the door-to-needle time in the
edian state increased by four min between 1998 and 1999
nd 2000 and 2001 (18). In this same time period, the
oor-to-balloon time in the median state decreased by 19
in; however, the power of this study to address the specific
uestion of time to reperfusion was limited; the median
able 3. Hospital Characteristics and Improvement*
Fibrinolytic
Therapy Cohort PCI Cohort
min/yr p min/yr p
verage 0.01 0.956 0.58 0.094
eographic location 0.500 0.046
New England 0.2 7.5
Middle Atlantic 0.2 0.8
South Atlantic 0.3 0.5
East North Central 0.3 0.5
East South Central 0.1 0.7
West North Central 0.5 1.6
West South Central 0.3 0.4
Mountain 0.2 1.1
Pacific 0.0 0.6
wnership 0.152 0.329
Public 0.2 0.8
Not-for-profit 0.1 0.6
Private 0.8 1.6
eaching 0.500 0.500
Urban/teaching 0.1 0.6
Urban/nonteaching 0.2 0.3
Rural/teaching 0.2 1.7
Rural/nonteaching 0.1 3.1
acilities 0.500 0.271
Open-heart surgery
program
0.3 0.5
Cardiac catheterization lab
only
0.2 1.9
Other 0.1
nnual volume 0.500 0.016
20 LYS or 15 PCI 0.1 1.0
20–40 LYS or 15–50 PCI 0.0 0.1
40 LYS or 50 PCI 0.0 1.9
eperfusion specialization 0.086 0.294
%LYS or %PCI 20% 6.0 2.3
%LYS or %PCI 20%–90% 0.6 0.4
%LYS or %PCI 90% 0.3 1.9
Adjusted for patient characteristics (from Table 1).
LYS  fibrinolytic therapy; PCI  percutaneous coronary interventiontate contributed only 17 patients to the number of patients ior the fibrinolytic therapy group and 6 to the PCI group
19). The size of the cohorts in our study and the focus only
n time to reperfusion enabled us to determine more precise
stimates and to investigate potential hospital-level predic-
ors of improvement.
Previous studies demonstrated that hospital volume pre-
icts lower door-to-needle (1) and door-to-balloon times
20). In addition to confirming these results for perfor-
ance, we further demonstrated the association of higher
umber of procedures with improvement in door-to-
alloon times. Thus, hospitals performing 50 PCIs/year
ot only started out with better times but managed to
mprove even more over the four years. In comparison,
igher-volume fibrinolytic therapy hospitals did not im-
rove more over the four-year study period than lower-
olume hospitals. The difference in complexity between
brinolytic therapy and PCI might account for these dis-
arate results. The PCI strategy, with involvement of the
nterventional cardiologist and the cardiac catheterization
aboratory in addition to the emergency department, is
nherently a more complex process than the fibrinolytic
trategy. A complex process such as PCI might benefit from
ore frequent use to identify more opportunities to im-
rove. Also, in contrast to the greater than two-decade
xperience with the fibrinolytic strategy, the PCI strategy
as only recently been widely adopted (7). More improve-
ent is likely seen early after introduction of a new strategy
han after one has become established.
Hospitals that predominantly treated patients with one
trategy (90% of the time) had better performance for that
trategy than those hospitals that had a more balanced profile.
ne explanation could be that there is a time delay associated
ith the decision of whether to administer fibrinolytic therapy
r perform PCI. Interestingly, improvement over the four years
as not statistically greater in these hospitals with a predom-
nant strategy compared with the balanced hospitals. More
nvestigation into the relationship between the strategies might
rovide valuable insights.
Our findings suggest that factors other than traditional
ospital characteristics are largely responsible for improvement
n door-to-reperfusion times seen in some hospitals. These
ndings might not be surprising in that management of AMI
nvolves many individuals, including nurses, physicians, tech-
ologists, and paramedics from different areas of the hospital,
uch as the emergency medical system, the emergency depart-
ent, and cardiology. In this setting, achieving rapid reperfu-
ion likely requires multifaceted, coordinated efforts at quality
mprovement specific to the institution. Qualitative approaches
uch as structured interviews and site visits might supplement
uantitative outcome analysis by supplying in-depth insight
nto the complex processes of care.
One potential explanation for a lack of significant im-
rovement in our analysis would be a “floor effect”—that no
urther improvement is possible. Although the low rates of
uideline adherence would suggest ample potential room for
mprovement for most hospitals, we included the mean of
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January 3, 2006:45–51 Improvement in Time to Reperfusion in STEMIhe first 10 cases for each hospital as a baseline covariate in
he model to account for this possibility and for potential
egression to the mean. Even adjusting for baseline perfor-
ance, many hospitals showed substantial improvement.
hus, a “floor effect” is not likely significantly limiting
pportunities for improvement. In-depth qualitative inves-
igation into hospitals with the best performance revealed
aluable strategies common to many of them (21). These
ualitative studies that identify optimal performance and
isseminate those strategies that have proven positive out-
omes complement the current analysis that identifies what
s being done in actual practice.
Whereas NRMI is a large database of more than one million
atients with AMI, certain issues are important to consider in
nterpreting our results. First, the database is voluntary and
ight not be representative of all patients presenting with
TEMI. Second, the membership of the cohort was not
onstant. Some hospitals started enrolling in NRMI during the
tudy period, others stopped; however, the results from a
maller cohort of patients from the hospitals that consistently
articipated throughout the study period were similar. Third,
he NRMI database might contain some patients for whom
here were legitimate delays in time to reperfusion. To decrease
he effect of extreme delays on our results, we only evaluated
atients treated with reperfusion therapy within 6 h and used
eometric mean times. Finally, we evaluated the hospital
haracteristics most frequently shown to be associated with
erformance, but other unmeasured structural characteris-
ics might exist that predict improvement.
In conclusion, the significant improvement in overall
oor-to-needle times seen in the 1990s seems to have
nded. Despite national initiatives to measure and reduce
hese times, guideline recommendations were met less than
ne-half of the time, with no substantial trend toward
mprovement. Nevertheless, some individual hospitals expe-
ienced substantial improvement while others worsened.
tructural features of hospitals such as volume and teaching
tatus do not adequately predict change in performance.
ther factors that are related to improvement, such as
rganizational culture, physician leadership, interrelation-
hip between cardiology and emergency physicians and staff,
mergency medical systems, and administrative support
eed to be identified and used by hospitals for performance-
mprovement programs to decrease door-to-needle and
oor-to-balloon times and decrease mortality from STEMI.
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